Latest filing published 29 Mar 2022 for Boston Scientific CORP, €262k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ian T. Meredith: trading record in brief
Ian T. Meredith appears in our data through filings on Boston Scientific Corp shares, published by SEC (Form 4). We count 52 filings; the first trade dates from 1 February 2018 and the latest from 28 March 2022.
Sales make up the whole of the open-market record (2 sales, €529k). The rest of the record consists of 27 share grants and 23 option exercises. Since January 2022: no purchases and 1 sale on the market.
The latest filing, published on 29 March 2022, reports an open-market sale of €262k in Boston Scientific Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ian T. Meredith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,588 shares@ US$43.6849.4% of flowCommon StockSEC:0001225208-22-005192:0
- 1,019 shares0Common StockSEC:0001225208-22-003862:0
- 1,013 shares0Common StockSEC:0001225208-22-003081:0
- 1,250 shares0Common StockSEC:0001225208-22-002921:0
- 1,108 shares0Common StockSEC:0001225208-22-002675:0
- 3,131 shares0Common StockSEC:0001225208-22-001307:0
- 3,649 shares0Common StockSEC:0001225208-22-000113:0
- 7,018 shares@ US$43.2150.6% of flowCommon StockSEC:0001225208-21-015271:0
8 of 8 declarations
